Investing in Disruptive Innovation in Health Care

Investment Sectors

Teal Ventures invests in early-stage companies focused on disruptive innovations in Health Technology. The Fund has a target portfolio composition of 50% women-founded or women-led companies.

Digital Technology — Digital Technology

Machine Learning, Natural Language Processing & Artificial intelligence — Machine Learning, Natural Language Processing & Artificial intelligence

Medical Devices — Medical Devices

Software-as-a-Service — Software-as-a-Service

Rapid Path Pharma — Rapid Path Pharma

Investment Strategy

Portfolio Companies

logosArtboard 4@2x.png

logosArtboard 4 copy 2@2x.png

Untitled design (13).png

logosArtboard 4 copy@2x.png

logosArtboard 4 copy 3@2x.png

logosArtboard 4 copy 5@2x.png

logosArtboard 4 copy 6@2x.png

logosArtboard 4 copy 4@2x.png

nudjArtboard 4 copy 13.png

logosArtboard 4 copy 7@2x.png

Untitled design (75).png

Portfolio Companies in the News

Onconova Acquires Trawsfynydd
To Form
Traws Pharma

nasdaq.com

Neuralace Medical Announces FDA Clearance of Axon Therapy for Chronic Painful Diabetic Neuropathy

prnewswire.com

Ram Fish Exploring Global Healthcare Innovation with Tobias Silberzahn from McKinsey & Company

19Labs.com

AT TEAL VENTURES WE BELIEVE VENTURE INVESTING IN EARLY-STAGE DIGITAL HEALTH IS A TEAM SPORT.

Teal Ventures

Team

Nikolay Savchuk

PhD
Partner

Read Bio
Eddie Rodriguez

JD
Partner

Read Bio
Ronald Demuth

MBA
Partner

Read Bio
Keith Winter

MBA, MS
Partner

Read Bio
Dr. Gelena Lifchitz

MD, MPH
Principal

Read Bio
Dr. Peter Fitzgerald

MD, PhD
Advisor

Read Bio
Augustine Lawlor

MPPM
Advisor

Read Bio

External Partners

Our external partners are invaluable members of our team.